Tissue-doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer

Journal of the American Society of Echocardiography

Volumn 24, Issue 2, 2011, Pages 200-206

  Appel, Jon M ^a   Sogaard, Peter ^a   Mortensen, Christiane E ^a   Skagen, Knud ^a   Nielsen, Dorte L ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adjuvant treatment; Anthracycline; Breast cancer; Cardiomyopathy; Cardiotoxicity; Epirubicin; Heart failure; Tissue Doppler echocardiography

Indexed keywords

EPIRUBICIN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEALTH STATUS; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79551524303     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.12.004     Document Type: Article

References (47)

1. J.M. Appel, D. Nielsen, B. Zerahn, B.V. Jensen, and K. Skagen Anthracycline-induced chronic cardiotoxicity and heart failure Acta Oncol 46 2007 576 580
2. D.D. Von Hoff, M.W. Layard, P. Basa, H.L. Jr. Davis, A.L. Von Hoff, and M. Rozencweig Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 1979 710 717
3. M. Ryberg, D. Nielsen, G. Cortese, G. Nielsen, T. Skovsgaard, and P.K. Andersen New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients J Natl Cancer Inst 100 2008 1058 1067
4. J.M. Appel, B.V. Jensen, D.L. Nielsen, M. Ryberg, and B. Zerahn Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer Int J Cardiovasc Imaging 26 2010 217 223
5. G. Mantovani, C. Madeddu, C. Cadeddu, M. Dessi, A. Piras, and E. Massa Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers Oncologist 13 2008 1296 1305
6. G. Mercuro, C. Cadeddu, A. Piras, M. Dessi, C. Madeddu, and M. Deidda Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers Oncologist 12 2007 1124 1133
7. F. Dodos, T. Halbsguth, E. Erdmann, and U.C. Hoppe Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults Clin Res Cardiol 97 2008 318 326
8. R. Jurcut, H. Wildiers, J. Ganame, J. Dhooge, B.J. De, and H. Denys Strain rate imaging detects early cardiac effects of pegylated liposomal doxorubicin as adjuvant therapy in elderly patients with breast cancer J Am Soc Echocardiogr 21 2008 1283 1289
9. C. Karakurt, G. Kocak, and U. Ozgen Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy Echocardiography 25 2008 880 887
10. A.C. Nagy, Z. Cserep, E. Tolnay, T. Nagykalnai, and T. Forster Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study Pathol Oncol Res 14 2008 69 77
11. M. Belham, A. Kruger, S. Mepham, G. Faganello, and C. Pritchard Monitoring left ventricular function in adults receiving anthracycline- containing chemotherapy Eur J Heart Fail 9 2007 409 414
12. J. Ganame, P. Claus, B. Eyskens, A. Uyttebroeck, M. Renard, and J. Dhooge Acute cardiac functional and morphological changes after anthracycline infusions in children Am J Cardiol 99 2007 974 977
13. F. Corapcioglu, N. Sarper, F. Berk, T. Sahin, E. Zengin, and H. Demir Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography Pediatr Hematol Oncol 23 2006 71 80
14. S. Tassan-Mangina, D. Codorean, M. Metivier, B. Costa, C. Himberlin, and C. Jouannaud Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study Eur J Echocardiogr 7 2006 141 146
15. L.C. Kremer, E.C. van Dalen, M. Offringa, J. Ottenkamp, and P.A. Voute Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study J Clin Oncol 19 2001 191 196
16. M.M. Abu-Khalaf, V. Juneja, G.G. Chung, M.P. DiGiovanna, R. Sipples, and M. McGurk Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer Breast Cancer Res Treat 104 2007 341 349
17. O. Hequet, Q.H. Le, I. Moullet, E. Pauli, G. Salles, and D. Espinouse Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults J Clin Oncol 22 2004 1864 1871
18. L. Elbl, H. Hrstkova, and V. Chaloupka The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer Eur J Pediatr 162 2003 690 696
19. L.J. Steinherz, T. Graham, R. Hurwitz, H.M. Sondheimer, R.G. Schwartz, and E.M. Shaffer Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group Pediatrics 89 1992 942 949
20. J. Suzuki, A. Yanagisawa, T. Shigeyama, J. Tsubota, T. Yasumura, and K. Shimoyama Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography Angiology 50 1999 37 45
21. M.D. Cheitlin, W.F. Armstrong, G.P. Aurigemma, G.A. Beller, F.Z. Bierman, and J.L. Davis ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) J Am Soc Echocardiogr 16 2003 1091 1110
22. B.W. Eidem Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough J Am Soc Echocardiogr 21 2008 1290 1292
23. M. Wang, G.W. Yip, A.Y. Wang, Y. Zhang, P.Y. Ho, and M.K. Tse Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value J Am Coll Cardiol 41 2003 820 826
24. R. Mogelvang, P. Sogaard, S.A. Pedersen, N.T. Olsen, J.L. Marott, and P. Schnohr Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population Circulation 119 2009 2679 2685
25. M. Wang, G.W. Yip, A.Y. Wang, Y. Zhang, P.Y. Ho, and M.K. Tse Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy J Hypertens 23 2005 183 191
26. M.D. Cheitlin, J.S. Alpert, W.F. Armstrong, G.P. Aurigemma, G.A. Beller, and F.Z. Bierman ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography Circulation 95 1997 1686 1744
27. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
28. M.W. Sessoms, J. Lisauskas, and S.J. Kovacs The left ventricular color M-mode Doppler flow propagation velocity V(p): in vivo comparison of alternative methods including physiologic implications J Am Soc Echocardiogr 15 2002 339 348
29. H. Takatsuji, T. Mikami, K. Urasawa, J. Teranishi, H. Onozuka, and C. Takagi A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography J Am Coll Cardiol 27 1996 365 371
30. S. Kaul, C. Tei, J.M. Hopkins, and P.M. Shah Assessment of right ventricular function using two-dimensional echocardiography Am Heart J 107 1984 526 531
31. M.J. Garcia, M.A. Ares, C. Asher, L. Rodriguez, P. Vandervoort, and J.D. Thomas An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure J Am Coll Cardiol 29 1997 448 454
32. S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, J.K. Oh, and M.M. Redfield Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study Circulation 102 2000 1788 1794
33. J. Ganame, P. Claus, A. Uyttebroeck, M. Renard, J. Dhooge, and B. Bijnens Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients J Am Soc Echocardiogr 20 2007 1351 1358
34. P.V. Escriba, M. Sastre, and J.A. Garcia-Sevilla Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures Proc Natl Acad Sci U S A 92 1995 7595 7599
35. V.I. Kapelko, C.P. Williams, D.E. Gutstein, and J.P. Morgan Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathy Arch Physiol Biochem 104 1996 185 191
36. S. Zhou, A. Starkov, M.K. Froberg, R.L. Leino, and K.B. Wallace Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin Cancer Res 61 2001 771 777
37. M. Tokarska-Schlattner, M. Zaugg, C. Zuppinger, T. Wallimann, and U. Schlattner New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics J Mol Cell Cardiol 41 2006 389 405
38. T. Nakamura, Y. Ueda, Y. Juan, S. Katsuda, H. Takahashi, and E. Koh Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study Circulation 102 2000 572 578
39. M.E. Billingham, J.W. Mason, M.R. Bristow, and J.R. Daniels Anthracycline cardiomyopathy monitored by morphologic changes Cancer Treat Rep 62 1978 865 872
40. J.W. Mason, M.R. Bristow, M.E. Billingham, and J.R. Daniels Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy Cancer Treat Rep 62 1978 857 864
41. S.A. Mortensen, H.S. Olsen, and U. Baandrup Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease Br Heart J 55 1986 274 282
42. J.I. Hoffman Transmural myocardial perfusion Prog Cardiovasc Dis 29 1987 429 464
43. R.A. Greenbaum, S.Y. Ho, D.G. Gibson, A.E. Becker, and R.H. Anderson Left ventricular fibre architecture in man Br Heart J 45 1981 248 263
44. J.P. Sun, Z.B. Popovic, N.L. Greenberg, X.F. Xu, C.R. Asher, and W.J. Stewart Noninvasive quantification of regional myocardial function using Doppler-derived velocity, displacement, strain rate, and strain in healthy volunteers: effects of aging J Am Soc Echocardiogr 17 2004 132 138
45. N.S. Chahal, T.K. Lim, P. Jain, J.C. Chambers, J.S. Kooner, and R. Senior Normative reference values for the tissue Doppler imaging parameters of left ventricular function: a population-based study Eur J Echocardiogr 11 2010 51 56
46. J. Robert Epirubicin. Clinical pharmacology and dose-effect relationship Drugs 45 suppl 1993 20 30
47. L. Babuin, and A.S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury CMAJ 173 2005 1191 1202